Background-The use of cardiac implantable electronic devices (CIED) is increasing, and their associated infections result in significant morbidity and mortality. The introduction of better cardiac imaging techniques could be useful for diagnosing this condition and guiding therapy. Our objective was to systematically assess the diagnostic accuracy of Fluor-18-fluorodeoxyglucose positron emission tomography and computed tomography, labeled leukocyte scintigraphy (LS), and Gallium-67 citrate scintigraphy for the diagnosis of CIED infection. Methods and Results-A systematic review of the literature and meta-analysis on the use of all 3 modalities in CIED infection were conducted. Pooled sensitivity, specificity, and summary receiver operating characteristic curves of each imaging modalities were determined. The literature search identified 2493 articles. A total of 13 articles (11 studies for 18 F-FDG PET-CT and 2 for LS), met the inclusion criteria. No studies for 67 Ga citrate scintigraphy met the inclusion criteria. The pooled sensitivity of 18 F-FDG PET-CT for the diagnosis of CIED infection was 87% (95% CI, 82%-91%) and pooled specificity was 94% (95% CI, 88%-98%). The summary receiver operating characteristic curve analysis demonstrated good overall accuracy, with an area under the curve of 0.935. There were insufficient data to do a metaanalysis for LS, but both studies reported sensitivity above 90% and specificity of 100%.
T he indications for and the use of cardiac implantable electronic devices (CIED) have increased dramatically worldwide. [1] [2] [3] This increase in implantation rate, however, has been accompanied by a greater increase in the rate of CIED infection. 4 These infections are associated with significant mortality and morbidity and warrant prompt medical treatment. 5 Infection can involve any portion of the device and can be further classified into CIED pocket infection or CIED lead/ infective endocarditis (IE) infection. Patient presentation can vary significantly, ranging from simple local swelling or pain at the site of the device pocket to nonspecific signs of systemic infection, and can occur days to years after implantation. 6, 7 The highly variable and nonspecific presentations of CIED infection make the diagnosis challenging. An accurate and timely diagnosis is paramount because therapy of all but the most superficial infections usually mandates device extraction and reimplantation, at considerable risk to the patient and cost to the payer.
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Investigation of patients with suspected CIED infection should include clinical information, physical examination, blood work and microbiological testing. Echocardiography is currently the first-line imaging technique in patients with suspected CIED infection, but is of limited value unless a PET and SPECT Imaging in CIED Infection vegetation is visualized along a lead. There is a need to identify a more accurate noninvasive test for the diagnosis of CIED infection, as well as a growing interest regarding the use of Fluor-18-fluorodeoxyglucose positron emission tomography and computed tomography ( 18 F-FDG PET-CT) for infection and inflammatory conditions. [8] [9] [10] Other tracers also exist with the potential to image infection; both 67 Ga scintigraphy and labeled leukocytes scintigraphy (LS) have demonstrated their use in inflammatory and infectious disease.
We sought to perform a systematic review and meta-analysis to establish the accuracy of 18 F-FDG PET-CT, 67 Ga citrate scintigraphy, and LS for the diagnosis of CIED infection in adult patients.
Methods
Peer-reviewed studies investigating the accuracy of 18 F-FDG PET-CT, 67 Ga citrate scintigraphy, or LS for the diagnosis of CIED infection were included. Only studies where sufficient data were provided to calculate true positives, true negatives, false positives, and false negatives were considered. Animal studies and pediatric studies were excluded, as were abstracts, case reports, and case series. For 67 Ga citrate and LS, only studies using single-photon emission computed tomography (SPECT) or SPECT-CT were included because planar imaging alone no longer reflects current practice.
The search strategy was developed and tested through an iterative process by an experienced medical information specialist in consultation with the review team. The database searches were executed on November 25 and 26, 2015. We searched Ovid MEDLINE, Ovid MEDLINE In-Process & Other Non-Indexed Citations, and Embase using the OVID platform and the CENTRAL database on Wiley. We searched PubMed for the most recent and unindexed citations only.
Strategies used a combination of controlled vocabulary (eg, "Endocarditis, Bacterial", "Fluorodeoxyglucose F18", and "Gallium Radioisotopes") and keywords (eg, endocarditis, 18F-FDG, and GA-67). Vocabulary and syntax were adjusted across databases. When possible, animal-only and opinion-pieces were removed from the results. We performed a targeted gray literature of major health technology assessment organizations and Google Scholar on December 4, 2015. Specific details about the strategies appear in Appendix I in the Data Supplement.
Two independent reviewers assessed all abstracts for adherence to inclusion criteria. All abstracts accepted by either reviewers were selected for full-text review. Any disagreements were resolved through consensus at this stage. A third author was consulted in cases where consensus could not be reached. The reference lists of studies meeting the inclusion criteria were reviewed for missed articles.
Absolute numbers for true positives, true negatives, false positives, and false negatives on a per examination basis were extracted from the included papers by one of the reviewer, and the extracted data were verified by the second reviewer. Using the extracted values, estimates of sensitivity and specificity, as well as their 95% confidence intervals, were obtained for each study as were pooled estimates of sensitivity and specificity using weighted averages according to the patient population size. The Cochran Q test and the Inconsistency Index I 2 were calculated and used to assess heterogeneity between studies. Summary receiver operating characteristic curves were also computed with area under the curve (AUC) reported as a measure of diagnostic accuracy. The shape of the curve was calculated using Moses constant-of-linear model under the assumption of symmetry. The threshold effect was assessed using the Spearman correlation between sensitivity and specificity. The Moses-Shapiro-Littenberg model, a form of metaregression that models the relationship between the diagnostic odds ratio and the diagnostic threshold of the test, was used to assess the ROC curve symmetry assumption. All analyses were performed using Meta-DiSc version 1.4 (Clinical Biostatistics Unit, Ramon y Cajal Hospital, Madrid, Spain). Positive predictive value and negative predictive value are dependent on the prevalence of the condition in the population and are most useful when it is known. For this reason, we decided to focus on sensitivity and specificity.
When sufficient data were provided to do so, subgroup analysis for pocket/generator infection and lead/IE were done. The same Tc-HMPAO, hexamethylpropyleneamine labeled with Technetium-99m; AC, attenuation corrected; CIED, cardiac implantable electronic device; CT, computed tomography; CTA, computed tomographic angiography; IE, infective endocarditis; LVAD, left ventricular assist device; NAC, nonattenuation corrected; PET, positron emission tomography; ROI, region of interest; SPECT, single-photon emission computed tomography; and SUV max , maximum standardized uptake value.
analysis and software as for the main analysis were used in these subgroup analyses.
Quality of Evidence
All included studies were assessed for risk of bias and applicability concerns using the Quality Assessment of Diagnostic Accuraccy Studies 2 (QUADAS-2) tool (Appendix II in the Data Supplement).
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Results
The literature search identified a total of 2493 abstracts, and 13 studies met the entry criteria ( Figure 1) ; no additional eligible studies were identified from the reference lists of studies meeting the inclusion criteria. A total of 11 studies (331 patients, 340 examinations) [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] and 2 studies (71 patients, 76 examinations) 23, 24 met the inclusion criteria for 18 F-FDG PET-CT and LS, respectively. There were no studies for 67 Ga citrate that met the criteria for inclusion. Pertinent study characteristics are summarized in Tables  1 and 2 . All included studies were single-center and published between 2010 and 2016, and 8 of 13 were prospective studies.
Diagnostic Accuracy of 18 
F-FDG PET-CT
All 11 studies were included in the meta-analysis. The pooled sensitivity of 18 F-FDG PET-CT for the diagnostic of CIED infection was 87% (95% CI, 82%-91%) and pooled specificity was 94% (95% CI, 88%-98%; Figure 2 ). The summary receiver operating characteristic curve analysis demonstrated good overall accuracy, with an AUC of 0.952 and a Q* of 0.89 ( Figure 3) . I 2 value for sensitivity and specificity were 56.6% and 0%, respectively, indicating the absence of substantial heterogeneity in specificity, and moderate heterogeneity in sensitivity among the studies included in the meta-analysis.
Left ventricular assist device infection can present differently than pacemaker and implanted cardioverter defibrillator infection. For this reason, a subanalysis excluding the single left ventricular assist device infection study 15 was performed. In the subanalysis, the results did not change significantly.
Location of Infection
A total of 4 studies [12] [13] [14] 17 provided sufficient information to calculate the operating characteristics of 18 F-FDG PET-CT for pocket/generator related CIED infection. Pooled specificity and sensitivity in this subgroup analysis were 93% (95% CI, 84%-98%) and 98% (95% CI, 88%-100%), respectively, and AUC was 0.981 ( Figure 4) . Six studies 13, 14, 16, 17, 19, 20 provided sufficient information to calculate the operating characteristics of 18 F-FDG PET-CT for lead or IE-related CIED infection. Pooled sensitivity was 65% (95% CI, 53%-76%), specificity was 88% (95% CI, 77%-94%), and AUC was 0.861 ( Figure 5 ).
Diagnostic Accuracy of LS
There were not enough studies to generate statistically meaningful pooled operating characteristics or a summary receiver operating characteristic. The largest study (n=63) reported a sensitivity of 94% and a specificity of 100%, whereas a small study that enrolled 13 left ventricular assist device patients reported sensitivity and specificity of 100%.
23,24
Quality of Included Studies
The QUADAS-2 analysis ( Figure 6 ) demonstrated that overall, there was low risk of bias and low concerns for applicability, except for risk of bias related to the reference standard. This is, in part, explained by the lack of a true, reliable "gold standard" in the diagnosis of CIED infection. In the majority of studies, the reference standard was either microbiological analysis on extracted device or clinical diagnosis and follow-up after a minimum length of time. In some studies, the examination results were either available to the team deciding on device extraction or making the final clinical diagnosis after follow-up, or it was unclear whether this information was made available to the medical team before treatment decision.
Discussion
This is the first systematic review and meta-analysis on the diagnostic accuracy of 18 F-FDG PET-CT and LS using SPECT or SPECT-CT in CIED infection. Our meta-analysis on the use of 18 F-FDG PET-CT demonstrated good accuracy, with a sensitivity of 87%, a specificity of 94%, and an AUC of 0.952. These data support the use of this modality in the investigation of suspected CIED infection. Although it is unclear whether it is cost-effective for all such patients to undergo 18 F-FDG PET-CT, the high accuracy of the examination appears ideal to help clinicians in appropriately classifying and stratifying patient with "possible" CIED infection after standard work-up. In light of the significant cost, morbidity and mortality associated with these infections, combined with the significant risk associated with device extraction, the importance of a timely and accurate diagnosis cannot be overstated. 25, 26 The ability of 18 F-FDG PET-CT to image all sites (pocket/generator, leads) of possible infection in one examination also represents a significant advantage, particularly when the extent of infection is uncertain (Figure 7) . The possibility to image extracardiac complications at the same time (septic emboli and metastatic infection) is another advantage of this technology. 27, 28 A proposed algorithm incorporating the use of 18 F-FDG PET-CT and LS in suspected CIED infection is presented in Figure 8 .
A subgroup analysis demonstrated a large difference between the accuracy of the test in the investigation of pocket/generator infection and lead/IE. Both pooled sensitivity (93%) and specificity (98%) were excellent in the pocket/ generator subanalysis. However, in the lead/IE subanalysis, although specificity was still good (88%), sensitivity was significantly lower at 65% (95% CI, 53%-76%). Although at first glance the results seem disappointing, it should be noted that most of the included studies were limited because they were not specifically designed to look for IE. Normal myocardium can demonstrate significant physiological uptake of FDG. Although this would be expected to have no impact on the diagnosis of pocket/generator or extracardiac lead infection, the absence of appropriate patient preparation to ensure myocardial suppression can certainly lower the test's accuracy leading to either false-positive results (physiological uptake falsely interpreted as infection) or false-negative results (infectious uptake overshadowed by diffuse physiological uptake). This has been well demonstrated in the cardiac sarcoid literature, and is supported by a recent meta-analysis by Tang et al, 29 who demonstrated that the accuracy of 18 F-FDG PET-CT is significantly affected by adequate cardiac preparation. The most recent guidelines of the American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging on cardiac PET recommend that a similar preparation should be used in patients with suspected IE or CIED infection, but only 2 of the 6 studies included in this subanalysis used an adequate cardiac preparation. 10 The sensitivity for the detection of lead infection may also be lower because the limited spatial resolution of PET limits the detection of small vegetations (<1 cm) and can lead to false-negative results. Some authors have proposed the use of a delayed acquisition (3 hours after tracer injection), and contrast-enhanced CT may help offset this limitation. 17, 19 Two studies 14, 16 had lower sensitivity than the other cohorts. Neither of these studies used cardiac preparation to suppress physiological myocardial FDG uptake. Graziosi et al 16 reported that 80% of the patients with false-negative results had received antibiotic therapy for at least 48 hours before undergoing 18 F-FDG PET-CT, and that diffuse myocardial FDG uptake (likely a result of the lack of cardiac preparation) was present in 50% of false-positive and 20% of false-negative. Cautela et al 14 also reported that 8 of 9 patients with false-negative examination had received previous antibiotic therapy.
Our systematic review could only identify 2 studies investigating LS in CIED infection using modern technology (SPECT alone or SPECT-CT) that met inclusion criteria. While this was not enough to do a meaningful meta-analysis or pooled analysis, it should still be noted that both studies reported excellent accuracy, with sensitivity of more than 90% and specificity of 100%. The specificity 18 F-FDG PET-CT was not made). That LS seems to be potentially more specific is not surprising; one of the weakness of FDG is its lack of specificity because increased glucose utilization can be seen in numerous neoplastic, postoperative, inflammatory and infectious process ( Figure 9 ). However, the labeled leukocytes will only accumulate over time in leukocyte recruiting infections. In this context, which examination to perform becomes primarily a question of availability and practicality. Assuming the use of a Technetium-99m labeled agent for LS, the effective radiation dose of both examinations are comparable (0.017 mSv/MBq with a recommended dose of 185-370 MBq for LS versus 0.019 mSv/MBq with a recommended dose of 2.5-5.0 MBq/kg for 18 F-FDG). 30, 31 The labeling process of LS is more cumbersome and requires the manipulation of blood product. LS is also lengthier; the examination requires the acquisition of images at 30 minutes, 4 to 6 hours and 20 to 24 hours after injection of the radiotracer. The entire 18 F-FDG PET-CT examination, including the waiting period after FDG injection and image acquisition, can be performed in <3 hours. However, it should be noted that PET-CT cameras are still less widely available than SPECT equipment. In centers where both technologies are available, the ease of use, speed and practicality of FDG trumps the potentially slightly increased specificity of LS. Regardless, LS remains an excellent examination when it is the only or most easily available option.
Limitations
The lack of a reliable "gold standard" for the diagnosis of CIED infection is a limitation in our study. Studies used either microbiological analysis on extracted devices or long-term clinical diagnosis and follow-up as a gold standard which, while subject to criticism, does represent real-life practice. The fact that in some studies the medical team was aware of the test results, and used those results in deciding between device extraction and conservative therapy may have created a bias and is another limitation.
Interpretation criteria for 18 F-FDG PET-CT are also still under investigation and development, as can be seen in the included studies. Nearly all studies reported good results with visual assessment, using both attenuation-corrected and nonattenuation-corrected images to account for attenuation correction artifacts commonly induced by the metallic portions of CIED. Criteria for quantitative and semiquantitative methods, however, are more heterogeneous and variable across studies. Some studies investigated the use of a standardized uptake value cut-off threshold or ratio; however, the methods used were too heterogeneous to permit a pooled analysis ( Table 3) .
The lack of adequate cardiac preparation to suppress physiological FDG myocardial uptake is also a limitation. This likely resulted in a lower sensitivity for 18 F-FDG PET-CT, particularly in the subanalysis for lead/IE-related CIED.
Some authors have reported false-negative 18 F-FDG PET-CT results in patients with extensive antibiotic therapy before imaging. As none of the studies were designed to assess the effects of previous antibiotic therapy on the accuracy of the tests, further studies will be required to determine the impact of antibiotics on 18 F-FDG uptake. Finally, it should be noted that there are no data available on the cost-effectiveness of these tests. Also, as a direct result of the included studies being designed to investigate the diagnostic performances of these tests, there are also no data on their impact on patient outcomes.
Conclusions
Both 18 F-FDG PET-CT and LS are useful and accurate for the diagnosis of CIED infection, based on our meta-analysis for 18 F-FDG PET-CT and limited data for LS. Prospective studies are warranted to further investigate the impact of these functional imaging tools on clinicians' decision-making and patients' outcome. 18 F-FDG PET-CT was ordered to rule out device infection. Images demonstrated a mild diffuse uptake along parts of the inflow and outflow cannulas, as well as most of the pump housing (black arrow, C). A more intense and focal area of uptake was also seen along the more medial aspect of the pump housing. This was interpreted as positive for infection, but considering the recent implantation, and the possibility that the FDG uptake might be related to postoperative inflammatory changes, labeled leukocytes scintigraphy (LS) with 99m Tc-HMPAO was also ordered. Both examinations were obtained <48 hours apart. LS planar images at 1 hour (D) and 3 hours (E) post injection demonstrated an area of uptake along the medial aspect of the pump housing (black arrow in D and E), with increasing uptake over time. Single-photon emission computed tomography-CT images obtained at 3 hours confirmed that this corresponds to the area of more focal uptake previously seen on 18 F-FDG PET-CT (white arrow in G and B, respectively). Cultures on explanted device were positive for Enterobacter and coagulasenegative Staphylococci, and confirmed that the infection was limited to the pump housing. This case illustrates the complimentary role of both modalities, particularly in the early postoperative setting, when diffuse inflammatory changes might make 18 F-FDG PET-CT interpretation more difficult. Semiquantitative ratio defined using maximum count rate around CIED and mean count rate of normal right and left lung parenchyma on NAC images AUC on ROC curve of 0.98 for the identification of patients who go on to require device extraction, with an optimal cut off of 2.0 (sensitivity of 97% and specificity of 98%)
Memmott et al 18 SUV max of visually identified hot spot, at both 90 and 180 min post FDG injection.
AUC on ROC curve of 0.96 at 90 min and 0.92 at 180 min for the diagnosis of patients with CIED infection Ratios using either SUV max (AC) or maximum count rate (NAC) of visually identified hot spot over lung parenchyma (mean count rate on NAC images), contralateral reference region (SUV mean on AC and mean count rate on NAC images), mediastinal blood pool (SUV mean ) and hepatic blood pool (SUV mean ). Ratios calculated at both 90 and 180 min post FDG injection
The accuracy of these methods varied significantly, with AUC on ROC curve between 0.71 and 0.97. The ratio using the hepatic blood pool was found to be the most accurate parameter studied, with an AUC on ROC curve of 0.94 at 90 min and 0.97 at 180 min for the diagnosis of patients with CIED infection Pizzi et al 19 SUV max of visually identified abnormal area Cut-off values found to be similar to patients' background value (1.21 for SUV max and 1.06 for SUV ratio) and of limited value because of poor specificity of 50% SUV ratio using SUV max of abnormal area and mean SUV of aortic blood pool AC indicates attenuation corrected; AUC, area under the curve; CIED, cardiac implantable electronic device; NAC, nonattenuation corrected; ROC, receiver operating characteristic; SUV max , maximum standardized uptake value; and SUV mean , mean standardized uptake value.
